Last updated on 4 Jul 2024
Owner Info
Revance Therapeutics, Inc.
7555 Gateway Blvd.
Newark CA 94560, UNITED STATES OF AMERICA
Serial Number
2171299 filed on 10 Feb 2021
Correspondent
Maren C. Perry King & Spalding LLP
1185 Avenue of the Americas,
New York NY 10036,
UNITED STATES OF AMERICA
2171299
10 Feb 2021
NA
FIGURATIVE
11 Aug 2020
US
Status Date | Action Taken |
---|---|
4th Jul 2024 | Status change to Voided |
29th Jun 2021 | International Registration in Australia Protected correspondence sent |
28th Jun 2021 | IP Right Registration Published |
28th Jun 2021 | Status change to Registered/Protected |
22nd Apr 2021 | Application Accepted correspondence sent |
21st Apr 2021 | IP Right has been Examined |
21st Apr 2021 | IP Right Acceptance Published |
21st Apr 2021 | Status change to Accepted |
20th Apr 2021 | Awaiting examination |
20th Apr 2021 | Examination expedited |